GrowingStockReport.com

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and MannKind Corp. (NASDAQ:MNKD) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 07/26/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and MannKind Corp. (NASDAQ:MNKD).

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) a company that develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally is currently up (+0.56%) on 433,846 shares traded after BioMarin Announced its Second Quarter 2013 Financial Results. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is currently up (+78.22%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States is currently up (+3.19%) on 4,424,297 shares traded. MannKind Corp. (NASDAQ:MNKD) is currently up (+314.29%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com